chartexchange

TXG
10x Genomics, Inc. Class A Common Stock
stockNASDAQ

Market OpenNov 17, 2026 10:27:49 AM EST
54.35USD-1.164%(-0.64)338,157
Pre-marketNov 17, 2026 8:10:30 AM EST
55.24USD+0.455%(+0.25)
46.41Bid61.50Ask15.09Spread
Loading…
Loading…
Healthcare
Health Information Services
HQ
Pleasanton, CA, USA
Previous Close
$54.97
Beta
2.48
52-Week High
$102.81 2026-10-06
52-Week Low
$15.18 2025-12-15
SMA 50
$73.77
SMA 200
$42.75
Avg. Vol 10D
3.11M
Avg. Vol 30D
3.82M
Avg. Vol 90D
3.31M
Relative Vol
0.09
131.53M
117.35M
12,473,112
0.4100%
2,300,000
Jul 16, 2006 · 2-for-1
TXG Profile

advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.

TXG Performance
PeriodPriceDateChangeBeta
1W62.902026-11-10-13.78%1.277
1M69.862026-10-16-22.37%3.832
3M57.992026-08-17-6.48%3.261
6M21.452026-05-18+152.82%2.971
1Y15.702025-11-17+245.41%2.478
2Y13.182024-11-18+311.46%—
5Y160.272021-11-17-66.16%2.128
TXG Stock Summary

10x Genomics, Inc. Class A Common Stock (NASDAQ:TXG) stock price today is $54.23, and today's volume is 331,332. TXG is down 1.382% today. The 30 day average volume is 3.82M. TXG market cap is $7.13B with 131.53M shares outstanding.